We examined if endogenous endothelins mediate the decreased HCO 3 
Introduction
Dietary acid increases acidification in the distal tubule in vivo (1) (2) (3) , but the factors that induce this response are unknown. This dietary maneuver might increase distal tubule acidification directly through changes in acid-base parameters of body fluids and/or indirectly by altering production of substances that modulate distal tubule acidification. In previous studies from this laboratory, animals ingesting the acid-producing salt (NH 4 ) 2 SO 4 increased distal tubule acidification and urine acid excretion without sustained changes in plasma acid-base parameters (3) . Furthermore, intracellular pH of cultured renal epithelial cells chronically (48 h) exposed to acid media was not different from control, yet these cells had increased Na ϩ /H ϩ antiporter activity (4) . These data suggest that persistent alterations in plasma or intracellular fluid acid-base parameters are not necessary to permit a sustained increase in renal epithelial acidification. Thus, dietary acid might increase distal nephron acidification indirectly by altering production of substances that more directly influence the components of distal tubule acidification. The mechanism by which the distal tubule increases acidification in response to dietary acid might suggest substances responsible for inducing the change. Our previous studies showed that dietary acid decreases HCO 3 secretion and increases H ϩ -secreting capacity in distal tubules in vivo (3) . Endothelin-1 (ET-1), 1 an agent made by collecting tubules (5) and renal microvascular endothelium (6) , decreases distal tubule HCO 3 secretion induced by dietary HCO 3 (7) and increases Na ϩ /H ϩ exchanger (NHE)-3 activity in cultured renal epithelia (8) . The data show that directional changes in components of distal tubule acidification induced by dietary acid are consistent with ET-1 actions on tubule HCO 3 /H ϩ secretion. The present studies used free-flow and in vivo microperfusion micropuncture to test the hypothesis that augmented endothelin secretion mediates increased distal tubule acidification induced by dietary acid. The data show that dietary acid increases ET-1 addition to renal interstitial fluid, a fluid with access to both the renal epithelium and endothelium. Furthermore, the studies show that endothelin receptor inhibition blunts both the decrease in distal tubule HCO 3 secretion and increase in H ϩ -secreting capacity induced by dietary acid. The data support the hypothesis that endothelin mediates the increase in distal tubule acidification induced by dietary acid.
Methods
Male and female Munich-Wistar rats (Harlan Sprague-Dawley Co., Houston, TX) weighing 240-271 g were used. Previous studies showed that dietary (NH 4 ) 2 SO 4 decreased HCO 3 secretion and increased H ϩ secreting capacity in the rat distal tubule in vivo (3) . We used the same (NH 4 ) 2 SO 4 -ingesting protocol in the present studies and these animals will be referred to as acid ingesting. Experimental and control animals eating a minimum electrolyte diet (ICN Nutritional Biochemicals, Cleveland, OH) received 40 mM (NH 4 ) 2 SO 4 drinking solution and distilled H 2 O, respectively, for 7-10 d before micropuncture. Because (NH 4 ) 2 SO 4 -ingesting animals had higher urine flow than control and because diuresis might increase urine ET-1 excretion (9), we studied a second control group ingesting 40 mM Na 2 SO 4 drinking solution that had similar drinking volumes and urine flows to (NH 4 ) 2 SO 4 animals. Bosentan (Hoffman-LaRoche, Basel, Switzerland), a nonpeptide endothelin A and endothelin B receptor antagonist (10), was infused (10 mg/kg i.v.) to antagonize actions of endogenous endothelins. This bosentan dose inhibits initial depressor and sustained pressor responses to ET-1 Ͼ 60% as long as 6 h (10). To distinguish endothelin A -from endothelin B -mediated effects, we infused a comparison animal group with BQ-123 (Bachem California, Torrence, CA), a selective endothelin A receptor antagonist (11), 1 mg/kg i.v. followed by 0.1 mg/kg per h. This BQ-123 dose inhibited pressor responses to both stimulated endogenous endothelins and infused ET-1 (12) .
Urine net acid excretion. Daily net acid excretion (NAE) was measured as described (13) (13) for NAE measurement. After anesthesia recovery and excreting blood-free urine, they returned to metabolic cages to continue their drinking solutions. We examined NAE in an additional set of bosentan-infused compared with vehicleinfused animals from each of the three experimental groups after they had ingested their drinking solutions and diet for 7 d. On the evening of the 7th day, animals were anesthetized as described and 10 mg/kg bosentan or vehicle infused into the jugular vein. The wound was closed with surgical clips and NAE was measured as described for the next 12 h.
Microdialysis technique for measurement of renal interstitial fluid ET-1. Renal interstitial fluid (RIF) ET-1 addition was estimated using microdialysis of the renal cortical interstitium (14) . A microdialysis apparatus was constructed from a 5-mm-long piece of hollow fiber dialysis tubing (molecular mass cutoff 5,000 D; Hospal, Meyzieu, France) with 0.1-mm inner diameter as described (14) . Each end of the dialysis tubing was connected to a 25-cm-long polyethylene tube (0.12-mm inner diameter, 0.65-mm outer diameter; Bioanalytical systems, Indianapolis, IN) and sealed in place with cyanoacrylic glue (14) . The left kidney was exposed through a flank incision in anesthetized rats and its renal capsule penetrated with a 31-gauge needle that was tunneled in the outer renal cortex ‫ف‬ 1 mm from the renal surface for ‫ف‬ 0.5 mm before exiting by penetrating the renal capsule again. The tip of the needle was inserted into one end of the dialysis probe and pulled together with the dialysis tube until the dialysis fiber was situated within the renal cortex. The flank wound was closed with clips and the inflow tube connected to a gas-tight syringe filled with lactated Ringer's infused at 3 l/min (Harvard Apparatus, Inc., South Natick, MA), as done by others (14) . To quantitate possible contamination of RIF with tubule contents caused by insertion of the microdialysis apparatus, we infused five animals having the microdialysis apparatus in place with a large amount ( I-ET-1 (ICM Biomedicals, Irvine, CA) perfused as described was 59Ϯ2%. ET-1 in RIF dialysate was measured using a RIA kit (Peninsula Laboratories Inc., Belmont, CA) after disposable column extraction (Sep-Pak C18; Millipore Corp., Milford, MA) preconditioned with methanol, H 2 O, and acetic acid as described (15) .
Micropuncture protocol. Animals were prepared for micropuncture of accessible distal tubules as described (16) . This distal nephron segment is comprised of multiple epithelia (17) but we will hereafter refer to it as the "distal tubule" for simplicity. Distal tubules were perfused at the early distal flow rate measured in situ (6 nl/min) (18) , calibrated in vitro, and verified in vivo (16) . Transepithelial potential difference was measured after perfusate collection for each solution (16) . An injected latex cast determined perfused tubule length after subsequent acid digestion of the kidney (16) . Anaerobically obtained arterial (0.35 ml) and stellate vessel blood plasma (16) was analyzed for tCO 2 using flow-through fluorometry (see below) (19) , and for pH, PCO 2 , and electrolytes (16) . Diet, but not drinking solution, was withheld the evening before studying micropunctured animals, yielding higher baseline HCO 3 reabsorption (20) and permitting differences in HCO 3 reabsorption to be more clearly seen. (16, 21) and H ϩ secretion (22) in the in vivo-perfused rat distal tubule. Thus, measuring luminal HCO 3 accumulation and voltage when perfusing with a zero HCO 3 , zero Cl Ϫ , and acetazolamidecontaining solution allows calculation of passive blood-to-lumen transepithelial HCO 3 permeability as done in our laboratory (16) and by others (23) . Solution 2 was used in this way. Solution 3 contained 5 mM HCO 3 for measurement of net HCO 3 reabsorption and for calculation of luminal H ϩ secretion using the apparent transtubule HCO 3 permeability derived from perfusing with solution 1 as described (16) . Solution 4 was identical to solution 3 except that it contained 10 rather than 5 mM NaHCO 3 . This perfusing solution helped to determine if a minimum attainable HCO 3 in distal tubule fluid limited net HCO 3 reabsorption in the (NH 4 ) 2 SO 4 -ingesting animals as previously reported from this laboratory (3). All perfusing solutions contained raffinose to minimize fluid transport and permit more focused study of HCO 3 transport (16). Three selected distal tubules were perfused in each animal of each group. One distal tubule was perfused with solution 1, another with solution 2, and the third was perfused in paired fashion (16) with solutions 3 and 4 in random order. The order of perfusing solutions was random.
Analytical methods. Immediately after experiment termination, initial and collected perfusate, as well as stellate vessel plasma samples, were analyzed for inulin as done previously (16) and for tCO 2 using flow-through ultrafluorometry (19) as done previously (24) . All tubule fluid and plasma tCO 2 were measured on the experimental day by comparing fluorescence of a 7-8-nl sample aliquot (corrected for a distilled H 2 O blank run with each sample group) to a standard curve as previously described (24) . This technique actually measures tCO 2 , but we will refer to this measured value as HCO 3 for simplicity.
Calculations. Net HCO 3 transport was the difference between perfused and collected rates. Net HCO 3 reabsorption refers to net HCO 3 transport obtained when perfusing with initially HCO 3 -containing solutions. Luminal HCO 3 accumulation describes net HCO 3 transport obtained when perfusing with initially HCO 3 -free solutions. A positive value for HCO 3 transport indicates net HCO 3 movement out of the lumen (reabsorption) and a negative one indicates net HCO 3 movement into the lumen (secretion). A transtubule HCO 3 permeability (P HCO3 ) was calculated as done previously (16) . The term "passive" HCO 3 permeability refers to that obtained when perfusing with zero HCO 3 , zero Cl Ϫ , and acetazolamide-containing solution (solution 2). By contrast, the term "apparent" permeability refers to transtubule HCO 3 permeability obtained when perfusing with zero HCO 3 , zero Cl Ϫ solution that contained no acetazolamide (solution 1). Bicarbonate secretion was estimated during perfusion with HCO 3 -containing solutions by calculating HCO 3 transport into the lumen using the apparent permeability derived from perfusing with the HCO 3 -free solution (16) . Thus, HCO 3 secretion ϭ apparent permeability ϫ transepithelial HCO 3 gradient corrected for transepithelial potential difference (16) . The same apparent permeability (derived perfusing with solution 1 as discussed) was used to calculate HCO 3 secretion when perfusing with both the 5 mM (solution 3) and 10 mM (solution 4) HCO 3 -containing solutions. By contrast, a unique transepithelial HCO 3 gradient was calculated for each HCO 3 -containing solution using respective tubule HCO 3 concentrations measured when perfusing with that solution (16) . The transepithelial potential difference used was the one measured when perfusing with the respective HCO 3 -containing solution. H ϩ secretion was estimated during perfusion with the HCO 3 -containing perfusates by subtracting calculated HCO 3 secretion from measured net HCO 3 reabsorption (16). This method for quantifying H ϩ secretion assumes that all HCO 3 transport from the lumen (absolute HCO 3 reabsorption) is mediated by luminal H ϩ secretion (22) . Furthermore, this method underestimates H ϩ secretion to the extent that HCO 3 entering the perfusing solution during perfusion is subsequently reabsorbed. The perfusing solutions contained no NH 3 /NH 4 ϩ for reasons previously discussed (25). Fluid reabsorption (J v ) was the difference between perfused and collected flow rates. All transport values were corrected for perfused tubule length (in mm).
Statistical analysis. The number comprising the three experimental groups represents animals and not tubules. Each reported animal had at least one successful distal tubule perfusion with each perfusing solution. The Bonferroni method was used for t test comparison of means (P Ͻ 0.05) when multiple different comparisons of the same parameter were done in animals among the three animal groups.
Results
General response to dietary protocols. There were no body weight differences between H 2 O (control), (NH 4 ) 2 SO 4 , and Na 2 SO 4 animals at the start (255Ϯ8, 254Ϯ6, and 244Ϯ6 g, respectively) or end (268Ϯ9, 263Ϯ6, and 257Ϯ6 g, respectively) of the experimental period. Food intake was not different among groups. Ingested drinking solution volume was higher in (NH 4 Effect of endothelin receptor inhibition on systemic blood pressure. Mean blood pressure of micropunctured animals was similar among bosentan-infused, BQ-123-infused, and baseline (NH 4 ) 2 SO 4 (110Ϯ3, 108Ϯ3, and 115Ϯ4 mmHg, respectively), control (111Ϯ4, 112Ϯ3, and 116Ϯ3 mmHg, respectively), and Na 2 SO 4 animals (107Ϯ3, 113Ϯ3, and 117Ϯ4 mmHg, respectively, P ϭ NS).
Micropuncture data. Because the (NH 4 ) 2 SO 4 -induced increased urine NAE was accompanied by augmented RIF ET-1 addition, we investigated whether endothelin receptor antagonism in vivo influenced the augmented distal tubule acidification induced by dietary (NH 4 ) 2 SO 4 (3). Plasma electrolyte and acid-base composition including arterial and stellate vessel plasma HCO 3 were not different among groups (data not shown). Table II depicts the effect of bosentan, a nonspecific endothelin receptor antagonist (10), and BQ-123, an ET A selective antagonist (11), on distal tubule HCO 3 transport in situ. In previous studies, (NH 4 ) 2 SO 4 animals had lower late distal fluid HCO 3 and lower HCO 3 delivery to this nephron segment than control (3). In the present studies, Table II shows that late distal tubule fluid HCO 3 was higher than baseline in (NH 4 ) 2 SO 4 animals given bosentan but not BQ-123. Late distal tubule fluid HCO 3 was higher in bosentan-treated compared with baseline (NH 4 ) 2 SO 4 animals despite similar fluid flows (2.0Ϯ0.2 vs. 1.8Ϯ0.2 nl/min, respectively, P ϭ NS) and tubular fluid-to-plasma inulin ratios (14.1Ϯ1.8 vs. 14.8Ϯ1.9, respectively, P ϭ NS). By contrast, early and late distal tubule HCO 3 delivery as well as net HCO 3 reabsorption were not different The final perfusion studies in (NH 4 ) 2 SO 4 animals examined if a minimal attainable HCO 3 might limit measured net HCO 3 reabsorption in distal tubules perfused with HCO 3 -containing solutions, limiting calculated H ϩ secretion in these animals, and possibly concealing an effect of bosentan on H ϩ secretion. Distal tubules were perfused with solution 4, containing a higher initial HCO 3 (10 mM) than solution 3, as discussed earlier. The data are depicted in Table VI . In previous studies, net HCO 3 reabsorption was higher in (NH 4 ) 2 SO 4 compared with control animals when distal tubules of each were perfused with 10 mM HCO 3 solution (3). Table VI shows lower net HCO 3 reabsorption in distal tubules of bosentan-infused but not BQ-123-infused (NH 4 ) 2 SO 4 animals. H ϩ and HCO 3 secretion for the 10-mM HCO 3 perfusions were calculated as for the 5-mM HCO 3 perfusions, using apparent permeability derived from the perfusion with solution 1 (see Methods). Fig. 4 shows that calculated HCO 3 secretion was higher in distal tubules of the bosentan-infused compared with the baseline (NH 4 ) 2 SO 4 animals perfused with 10 mM HCO 3 , P ϭ NS). In contrast with the findings described when perfusing with the 5-mM HCO 3 solutions, Fig. 5 , P ϭ NS). Thus, decreased H ϩ secretory capacity contributes to higher HCO 3 at the late distal tubule in situ of bosentan-infused (NH 4 ) 2 SO 4 animals.
We next examined the effect of bosentan on HCO 3 transport in control animals. Table VII shows no difference in luminal HCO 3 accumulation or apparent permeability between bosentan-infused and baseline controls perfused with solution 1 (zero HCO 3 ). Because differences in net HCO 3 reabsorption between (NH 4 ) 2 SO 4 animals and control were evident perfusing with the 10 but not 5 mM HCO 3 solution, the 10-mM solution (solution 4) was perfused in distal tubules of control animals to determine if bosentan influenced net HCO 3 reabsorption and/or its components (HCO 3 /H ϩ secretion) in control animals. , P ϭ NS) were also not different in bosentan-infused and baseline controls, respectively. Thus, endothelin receptor antagonism did not affect distal tubule acidification in control animals.
The final series of microperfusion studies determined if bosentan influenced distal tubule HCO 3 transport in Na 2 SO 4 animals, a group whose urine flow was higher than control but comparable to that for (NH 4 ) 2 SO 4 animals. This higher urine flow might itself increase urine ET-1 excretion (9) and thereby influence distal tubule acidification independent of dietary acid intake. Table IX shows no difference in luminal HCO 3 accumulation or apparent permeability between bosentan-infused and baseline Na 2 SO 4 animals perfused with solution 1 (zero HCO 3 ). As with the control animals, the 10-mM HCO 3 solution (solution 4) was used in distal tubules of Na 2 SO 4 animals to determine if bosentan influenced net HCO 3 reabsorption and/or its components in this group. , P ϭ NS) were also not different in bosentan-infused and baseline Na 2 SO 4 animals, respectively. Thus, endothelin receptor antagonism did not affect distal tubule acidification in Na 2 SO 4 animals.
Effect of endothelin receptor inhibition on NAE. Because bosentan decreased acidification in the distal tubule of (NH 4 ) 2 SO 4 animals, we investigated if this receptor antagonist reduced NAE. 12-h NAE after administration of the same bosentan dose (10 mg/kg i.v.) that had been given to micropunctured animals was not different in bosentan-infused compared with vehicle-infused (NH 4 ) 2 SO 4 (3.2Ϯ0.5 vs. 4.1Ϯ0.6 meq/12 h, respectively, P ϭ NS), control (1.7Ϯ0.3 vs. 1.7Ϯ0.2 meq/12 h, respectively, P ϭ NS), or Na 2 SO 4 (1.7Ϯ0.2 vs. 1.8Ϯ0.2 meq/12 h, respectively, P ϭ NS) animals.
Discussion
Many investigations employing a variety of techniques have defined effector mechanisms by which the kidney increases acidification in response to dietary acid (26) . Such investigations show an important role of increased distal nephron acidification in this response (1) (2) (3) (27) (28) (29) . The distal tubule of animals ingesting dietary acid have augmented H ϩ secreting capacity (1-3) and reduced HCO 3 delivery to the terminal distal nephron (3, 30) , the latter facilitating increased titration of non-HCO 3 buffers (28, 31) . Recent studies from our laboratory show that reduced distal tubule HCO 3 secretion contributes to the decreased terminal distal nephron HCO 3 delivery induced by dietary acid (3). Thus, dietary acid alters both components of distal tubule net HCO 3 reabsorption (H ϩ /HCO 3 secretion) in a direction that increases acidification, but the immediate stimulus that induces this response is not known. Much less is understood about the mechanisms that induce distal nephron epithelia to respond in this way to a dietary acid challenge. Dietary acid-induced alterations in body fluid acid- base parameters might increase distal nephron acidification directly. Although changes in environmental acid-base parameters can induce predictable alterations in acidification of renal epithelia studied in vitro (32, 33) , it is clear that sustained changes in plasma (3, 24) or intracellular (4) acid-base parameters are not necessary to maintain altered renal epithelial acidification (3, 4, 24) . Alternative or additional mechanisms include diet-induced modification of the level and/or activity of secretory substances that modify renal epithelial acidification. The present studies tested the hypothesis that endothelin mediates increased distal tubule acidification induced by dietary acid. This hypothesis derives from studies showing that ET-1 increases NHE-3 activity in cultured renal epithelial cells (8) and decreases distal tubule HCO 3 secretion induced by dietary HCO 3 (7) . The data show that animals given dietary acid have greater ET-1 addition to RIF. Furthermore, B-but not A-type endothelin receptor inhibition blunts decreased HCO 3 secretion and increased H ϩ -secreting capacity induced by dietary acid. Endothelin receptor inhibition had no measurable effect on distal tubule acidification in control animals, suggesting that endothelin contributes less to the "tonic" level of distal tubule acidification under control conditions. The data support the hypothesis that endothelin mediates increased distal tubule acidification induced by dietary acid.
Although the endothelins were initially noted for their vasoactive effects (34), these agents also modulate epithelial transport by inhibiting the amiloride-sensitive Na ϩ channel (35) and ADH-mediated H 2 O reabsorption (36) in collecting tubules. ET-1 also stimulates the Na ϩ /H ϩ exchanger in renal cortical membrane vesicles (37) and the NHE-3 isoform in renal epithelial cells (8) , supporting a possible endothelin role in modulating renal acidification in vivo. The NHE performs much of the H ϩ secretion in the rat distal tubule accessible to micropuncture (38) . ET-1 also inhibits agonist-stimulated increases in cellular cyclic AMP levels in renal epithelium (36), a cellular second messenger whose increase is associated with augmented HCO 3 secretion in cortical collecting tubules (39) and with inhibited NHE activity in renal brush border membranes (40) . Preliminary studies show that ET-1 decreases distal tubule HCO 3 secretion induced by dietary HCO 3 (7) , an important response to this dietary maneuver (24) . By contrast, ET-1 inhibited net HCO 3 reabsorption in proximal straight tubules (41) , suggesting distinct ET-1 effects on acidification in this nephron segment. The present studies show that endothelin receptor inhibition blunts decreased HCO 3 secretion and increased H ϩ secretion in the distal tubule induced by dietary acid (3). The data suggest that endogenous endothelins mediate the decreased HCO 3 secretion and increased H ϩ secretion induced by dietary acid.
The present studies show that dietary acid increases ET-1 addition to RIF, a fluid compartment in direct communication with basolateral surfaces of cortical renal epithelium. This anatomical arrangement would permit endothelins secreted into RIF to modulate cortical epithelial transport through endothelin receptors on the surface of cultured canine cells of distal nephron origin (42) . Furthermore, rat cortical collecting tubules contain mRNA for the B-type endothelin receptor (43) , which the present studies suggest mediates the described actions of endogenous endothelins. Endothelins in the RIF might derive from collecting tubule epithelium (5) or endothelium of the renal microvasculature (6, 44) . The latter is separated from distal tubules in vivo by only a very narrow interstitial space (45) , permitting paracrine or autocrine communication among cell types. In addition, microdissected cortical collecting tubules contain ET-1 mRNA (43, 46) , and ET-1 is on the endothelial surfaces of peritubular capillaries (44) . The present studies show that dietary acid increases RIF ET-1 addition and suggest that the added ET-1 subsequently increases distal tubule acidification.
Calculated HCO 3 and H ϩ secretion were not different in bosentan-infused control animals, in contrast with the (NH 4 ) 2 SO 4 animals in which bosentan increased HCO 3 secretion and decreased H ϩ secretory capacity. Although a higher bosentan dose might influence control HCO 3 /H ϩ secretion, the data suggest that endogenous endothelins have a greater influence on basal distal tubule acidification in acid-ingesting compared with control animals. By contrast, endogenous endothelins apparently contribute less than intrinsic, neural, or other autocrine/paracrine mechanisms to basal distal tubule acidification. Nevertheless, the same bosentan dose that reduced distal nephron acidification in (NH 4 ) 2 SO 4 animals did not reduce augmented NAE in these animals. This suggests less endothelin effect on acidification and/or less sensitivity to the administered bosentan dose in more terminal nephron segments.
The present studies support that endogenous endothelins inhibit distal tubule HCO 3 secretion and stimulate H ϩ secretion in this nephron segment, but do not indicate the cellular signaling mechanisms that mediate these effects. Increased cellular cAMP levels are associated with stimulated HCO 3 secretion by the collecting tubule (39) and with inhibited Na ϩ /H ϩ exchange in brush border membranes (40) . In addition, ET-1 inhibits agonist-induced increases in cortical collecting tubule cAMP (36), complimenting the ET-1 effects on distal tubule HCO 3 secretion. Furthermore, prostacyclin (PGI 2 ), an agent that increases cellular cAMP levels in distal nephron epithelia (47) , increases distal tubule HCO 3 secretion (48) . Yet, ET-1 also stimulates Ca 2ϩ release from internal stores and its entry into cortical collecting duct cells (49) , consistent with activation of phospholipase C (50). In addition, activation of the B-type endothelin receptor leads to generation of nitric oxide through a tyrosine kinase-dependent and Ca 2ϩ /calmodulindependent pathway (51) . Thus, ET-1 might alter HCO 3 /H ϩ secretion by these and possibly other mechanisms.
In summary, the present studies show that reduced HCO 3 secretion and increased H ϩ secretory capacity in the distal tubule induced by dietary acid is associated with increased ET-1 addition to RIF. Furthermore, inhibition of B-but not A-type endothelin receptors blunts the reduced HCO 3 secretion and increased H ϩ secretory capacity induced by dietary acid, but does not affect distal tubule acidification in control animals. The data suggest that endogenous endothelins mediate increased distal tubule acidification induced by dietary acid but contribute less to basal acidification in this segment.
